Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour

Vermeer, 1986, Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase, Circulation, 74, 1379, 10.1161/01.CIR.74.6.1379 Weaver, 1995, Time to thrombolytic treatment: factors affecting delay and their influence on outcome, J Am Coll Cardiol, 25, 3S, 10.1016/0735-1097(95)00108-G Reimer, 1977, The wavefront phenomenon of ischemic cell death: 1 myocardial infarct size versus duration of coronary occlusion in dogs, Circulation, 56, 786, 10.1161/01.CIR.56.5.786 1994, Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients, Lancet, 343, 311, 10.1016/S0140-6736(94)91161-4 Flameng, 1990, Determinants of infarct size in non-human primates, Bas Res Cardiol, 85, 392, 10.1007/BF01907131 Reimer, 1993, Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models, Am J Cardiol, 72, 13G, 10.1016/0002-9149(93)90102-I Dorado, 1987, Myocardial infarction in the pig heart model: infarct size and duration of coronary occlusion, Cardiovasc Res, 21, 537, 10.1093/cvr/21.7.537 Schaper, 1987, Influence of collateral blood flow and of variations in MVO2 on tissue-ATP content in ischemic and infarcted myocardium, J Mol Cell Cardiol, 19, 19, 10.1016/S0022-2828(87)80542-4 Hermens, 1992, Effect of thrombolytic treatment delay on myocardial infarction size, Lancet, 340, 1297, 10.1016/0140-6736(92)93003-6 McNeill, 1991, Thrombolytic therapy within one hour of the onset of acute myocardial infarction, Q J Med, 79, 487 Davies, 1984, Prevention of myocardial infarction by very early treatment with intracoronary streptokinase, N Engl J Med, 311, 1488, 10.1056/NEJM198412063112306 1986, Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction, Lancet, i, 397 Van de Werf, 1988, , for the European Cooperative Study Group for recombinant tissue type plasminogen activator: intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction, BMJ, 297, 1374, 10.1136/bmj.297.6660.1374 McNeill, 1989, A double-blind placebo-controlled study of early and late adminstration of recombinant tissue plasminogen activator in acute myocardial infarction, Br Heart J, 61, 316, 10.1136/hrt.61.4.316 Schofer, 1990, Prehospital thrombolysis in acute myocardial infarction, Am J Cardiol, 66, 1429, 10.1016/0002-9149(90)90528-9 Barbash, 1990, Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction, Am J Cardiol, 66, 261, 10.1016/0002-9149(90)90832-L Castaigne, 1989, Pre-hospital use of APSAC: results of a placebo-controlled study, Am J Cardiol, 64, 30A, 10.1016/0002-9149(89)90927-2 McAleer, 1992, Prehospital thrombolysis in a rural community: short and long-term survival, Cardiovasc Drugs Ther, 6, 369, 10.1007/BF00054183 1992, : Grampian region early anistreplase trial, BMJ, 305, 548, 10.1136/bmj.305.6853.548 Weaver, 1993, Prehospital-initiated vs hospital–initiated thrombolytic therapy: the Myocardial Infarction Triage and Intervention Trial, JAMA, 270, 1211, 10.1001/jama.1993.03510100061033 1993, Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction, N Engl J Med, 329, 383, 10.1056/NEJM199308053290602 Fath-Ordoubadi, 1994, Meta-analysis of randomised trials of prehospital versus hospital thrombolysis, Circulation, 90, I-325 Fath-Ordoubadi, 1994, Fibrinolytic therapy in suspected acute myocardial infarction, Lancet, 343, 912, 10.1016/S0140-6736(94)90029-9 Honan, 1990, Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta–analysis, J Am Coll Cardiol, 16, 359, 10.1016/0735-1097(90)90586-E Kennedy, 1983, Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction, N Engl J Med, 309, 1477, 10.1056/NEJM198312153092402 Verstraete, 1985, Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction, Lancet, ii, 965, 10.1016/S0140-6736(85)90523-9 Simoons, 1985, Improved survival after early thrombolysis in acute myocardial infarction: a randomised trial by the Interuniversity Cardiology Institute in The Netherlands, Lancet, ii, 578, 10.1016/S0140-6736(85)90584-7 Ikram, 1986, Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex, BMJ, 293, 786, 10.1136/bmj.293.6550.786 1986, A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.): mortality, morbidity, and infarct size at 21 days, N Engl J Med, 314, 1465, 10.1056/NEJM198606053142301 White, 1987, Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N, Engl J Med, 317, 850, 10.1056/NEJM198710013171402 1988, Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2, Lancet, ii, 349 1988, Effects of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial, Lancet, i, 545 Wilcox, 1988, , for the ASSET Study Group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction, Lancet, ii, 525, 10.1016/S0140-6736(88)92656-6 Brunelli, 1988, Peaking time of creatine-kinase MB in patients treated with urokinase or conventionally during acute myocardial infarction: is it really a clue to reperfusion?, Cardiologia, 33, 669 1988, Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 h after onset of myocardial infarction, Lancet, i, 203 O'Rourke, 1988, Limitation of myocardial infarction by early infusion of recombinant tissue–type plasminogen activator, Circulation, 77, 1311, 10.1161/01.CIR.77.6.1311 Kennedy, 1988, The Western Washington intravenous streptokinase in acute myocardial infarction randomized trial, Circulation, 77, 345, 10.1161/01.CIR.77.2.345 Rentrop, 1989, Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction: report from the second Mount Sinai-New York University reperfusion trial, Circulation, 90, 1166, 10.1161/01.CIR.80.5.1166 Armstrong, 1989, Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction, J Am Coll Cardiol, 13, 1469, 10.1016/0735-1097(89)90334-3 1990, Very early thrombolytic therapy in suspected acute myocardial infarction, Am J Cardiol, 65, 401, 10.1016/0002-9149(90)90800-G 1993, Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 h after onset of acute myocardial infarction, Lancet, 342, 759, 10.1016/0140-6736(93)91538-W 1993, Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction, Lancet, 342, 767, 10.1016/0140-6736(93)91539-X Rossi, 1991, , on behalf of Urochinasi per la Sistemica nell'Infarto Myocardico (USIM) Collaborative Group. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction, Am J Cardiol, 68, 585, 10.1016/0002-9149(91)90348-O 1992, ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction, Lancet, 339, 753, 10.1016/0140-6736(92)91893-D Brunelli, 1991, Thrombolysis in refractory unstable angina, Am J Cardiol, 68, 110B, 10.1016/0002-9149(91)90393-Y Bär, 1992, Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome: results of UNASEM, a multicenter, randomised, placebo-controlled, clincial trial with anistreplase, Circulation, 86, 131, 10.1161/01.CIR.86.1.131 1994, Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-q-wave myocardial infarction: results of the TIMI IIIB trial, Circulation, 89, 1545, 10.1161/01.CIR.89.4.1545 Simoons, 1993, Tailored thrombolytic therapy. A perspective, Circulation, 88, 2556, 10.1161/01.CIR.88.6.2556 Turi, 1986, Implications for acute intervention related to time of hospital arrival in acute myocardial infarction, Am J Cardiol, 58, 203, 10.1016/0002-9149(86)90047-0 Yarzebski, 1994, Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: the Worcester heart attack study, Am Heart J, 128, 255, 10.1016/0002-8703(94)90477-4 Bouten, 1992, Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction, Eur J Heart, 13, 925, 10.1093/oxfordjournals.eurheartj.a060294 1996, Acute myocardial infarction: pre-hospital and in-hospital management. The task force on the management of acute myocardial infarction of the European society of cardiology, Eur Heart J, 17, 43, 10.1093/oxfordjournals.eurheartj.a014691